is there still a semaglutide shortage Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Semaglutide shortage ends as FDA

In terms of switching, 22.9% of the GLP-1 receptor agonist users and 2.1% of the SGLT2 inhibitor users switched between drugs within the same drug class

Join our upcoming webinar to discover how advanced LC-MS workflows are transforming GLP-1 peptide characterization

GLP-1 medications such as Ozempic and Wegovy have helped many people achieve significant weight loss and better overall health

Health Canada is warning the public of seized unauthorized injectable peptide drugs from Canada Peptide

The GLP-1 supplement Market size is projected to grow from $2.23 billion in 2026 to $5.52 billion by 2034, at a CAGR of 11.9% during the forecast period 2026-2034.

So, it's infuriating to get ads like this